ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Featured News

<< First  < Prev   ...   11   12   13   14   15   Next >  Last >> 
  • 10 Apr 2013 9:02 AM | Russell Benefield

    Request for Proposals

    Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals that evaluate the epidemiology and burden of pneumococcal disease in adults with underlying disease comorbidities and/or those living in long-term community settings.




    The 2013 ASPIRE Awards in Adult Vaccine Research are open to all investigators (senior and junior) provided that specific eligibility requirement are met. Applicants currently enrolled in a fellowship or postdoctoral program are eligible provided the applicant identifies an experienced mentor.  Applicants currently enrolled in a residency program are NOT eligible.


    Available Awards

    Pfizer is funding awards up to a maximum of $100,000 USD* each (including direct costs, institutional overhead costs, and indirect costs) for one year.

    Independent, External Review Committee

    The ASPIRE applications will be reviewed by an independent, external review committee comprised of medical and scientific experts.  Grants will be awarded based upon: 

    • Scientific merit of the research proposal

    • Qualifications of the applicant

    • Relevance of proposed research to the program's mission

    • Evidence of the applicant's commitment to an academic research career

    • Evidence of a suitable research environment

    Application Deadline

    Applications must be received by 11:59pm EST on July 2, 2013.

    For more information about this and other competitive research grant programs, please visit


    2013 ASPIRE Award brochure 

  • 20 Nov 2012 12:58 PM | Russell Benefield

    Thank you to members Joe Kuti and Katie Suda for representing SIDP in the CDC/Center for Disease Dynamics, Economics & Policy/Robert Wood Johnson Foundation tele-briefing to release the "Joint Statement on Antibiotic Resistance".  SIDP was one of four organizations (IDSA, SHEA, SIDP, Pew) that were on the call to answer questions.  Approximately 50 different health and non-health media outlets were on the call including CBS, Wired Magazine, and The Lancet.  Links to the audio recording and to the CDC "Get Smart About Antibiotics" webpage are below.


    Joint Statement Tele-briefing


    CDC Get Smart

  • 12 Nov 2012 2:04 PM | Russell Benefield

    Dear SIDP Members:

    Below please find updated information from the CDC regarding the Fungal Meningitis Outbreak, including a new telephone consultation network and unusual complications associated with the outbreak.


    We are writing to request your organization’s assistance in sharing the following information about the ongoing multistate outbreak of fungal meningitis and other infections: 

    1. the availability of a new telephone-based Clinicians Consultation Network service to assist clinicians treating patients who received injections with the contaminated steroid medication; and
    2. recent indications of two unusual clinical complications – epidural abscess and arachnoiditis – among a portion of patients undergoing treatment for meningitis associated with injections of a contaminated steroid medication, preservative-free methylprednisolone acetate.

    Clinicians Consultation Network


    Beginning on November 6, CDC is establishing a volunteer Clinicians Consultation Network of experts in fungal disease treatment and management to assist physicians who are directly involved in the treatment of patients associated with the current outbreak of fungal meningitis and other infections. Through this service, doctors who are treating patients will be able to consult by telephone or email with one of a group of participating infectious disease medical experts.  To access the service, physicians should call 1-800-CDC-INFO (1-800-232-4636) and then select the appropriate prompts (e.g., “1” for English, “1” for Clinician).  A CDC-INFO call agent will verify each physician’s role in direct patient management.  After this verification, the calling physician will be referred to the Clinicians Consultation Network.  The Network consultants have entered into volunteer agreements with CDC to provide this consultation service to treating physicians. There is no charge for the consultation.  The consultants will report their findings to CDC, which may provide valuable information for the response to the outbreak.  Operating hours for the service are the same as those for CDC-INFO:  8:00 am to 8:00 pm Monday through Friday (Eastern Time), except federal holidays.  


    If you have questions about the Clinicians Consultation Network, please contact CDC-INFO (1-800-232-4636).  


    New Information on Clinical Course


    During the course of this investigation, CDC has worked closely with a group of fungal infectious disease experts who provided their individual input to help CDC develop interim guidance and other information about clinical aspects of the outbreak, including patient management and treatment.  The guidance documents have been updated regularly as CDC and its partners have learned more about the outbreak; the latest versions are available on CDC’s outbreak-related Clinician Guidance webpage at  CDC has also advised that healthcare providers involved in the treatment of these patients consult with an infectious disease medical specialist because of the diagnostic and clinical challenges presented by these fungal infections. 


    CDC has recently become aware of reports of epidural abscess and arachnoiditis among a number of patients undergoing treatment for fungal meningitis associated with injections of contaminated steroid.  Spinal epidural abscesses are characterized by inflammation and a collection of pus around the spine, sometimes resulting in swelling of the infected areas (though several recently reported patients with this condition had no detectable swelling).  Arachnoiditis is caused by inflammation of the arachnoid, one of the membranes that surround and protect the nerves of the spinal cord.  Both conditions are normally rare but serious disorders that require prompt medical attention.   Most of these early reports have been for patients in Michigan and Tennessee, but other states have reported patients with these conditions as well. CDC is working with clinicians and public health officials to obtain more information and refine its clinical guidance as needed.  


    For additional information about the outbreak of fungal meningitis and other infections, see CDC’s website at   


    Best Regards,


    Erika Ernst

    President, SIDP

  • 30 Oct 2012 2:00 PM | Russell Benefield

    We hope you enjoy the new look and feel of our website.  Based on feedback from our members we've attempted to streamline content and make the website more user-friendly.  Our new website has several additional functionalities which we plan to implement over the coming months to make it a better resource for you.  During this transition we encourage you check back frequently and share any suggestions you have for improving the website in our forum Suggestions for the New Website? 

  • 28 Oct 2012 9:17 AM | Russell Benefield
    The CDCs National Healthcare Safety Network (NHSN) will re-launch the Antimicrobial Use and Resistance (AUR) Pharmacy Option to electronically collect data on antimicrobial use in April 2011. The following vendors are aware of this new reporting functionality and have expressed interest in providing services and software that will allow participation in the AUR pharmacy module through direct reporting. What follows is a list of vendors and appropriate vendor contacts for information regarding the AUR pharmacy module. Click here for a PDF listing.
    This information is provided as a service to SIDP members and registrants of the Antimicrobial Stewardship Certificate Program. This does not constitute an endorsement of these services and SIDP make no guarantees or warranties express or implied. Each facility must determine whether a vendor can meet their needs and which vendor, if any, will provide the services to best match their requirements
<< First  < Prev   ...   11   12   13   14   15   Next >  Last >> 

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events


Society of Infectious Diseases Pharmacists • PO Box 1488, Warrenville, IL 60555
(331) 248-7888
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software